NEWSROOM
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
POMPANO BEACH, FLORIDA, December 19, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces it has appointed Mr. Patrick Daly to its Board of Directors. Mr. Daly is an award-winning executive leader with a strong track record of success in operations, strategy, sales, marketing, fundraising, and partnership-building. BioStem...
PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?
NEW YORK, NY, December 18, 2023 - Shares in Battalion Oil Corporation (NYSE American: BATL) surged more than 80% on Friday after the company announced it has agreed to be acquired by Fury Resources, Inc. for $9.80 per share in cash, which represents a total transaction value of approximately $450 million. The transaction is expected to close in the first quarter of 2024. https://prismmarketview.com/companies/trio-petroleum-corp/ Battalion’s CEO, Matt Steele, commented, “It has been a pleasure...
MindMed Advances Treatment for Generalized Anxiety Disorder
NEW YORK, NY, December 18, 2023 - Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in generalized anxiety disorder (GAD). The trial met its primary endpoint, with MM-120 demonstrating statistically significant and clinically meaningful dose-dependent improvements. https://prismmarketview.com/companies/mind-medicine-mindmed-inc/ Robert Barrow, Chief Executive Officer and Director of MindMed,...
SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange
Phoenix, AZ, December 18, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a renewable solar energy and sustainable solutions provider participated in the iconic opening bell ringing ceremony, Friday December 15th, 2023. The event marked the successful listing of the Company’s common stock on the Cboe BZX Exchange. “It was a pleasure to initiate the Cboe opening bell in celebration of our listing,” said Ralston CEO SinglePoint Inc. “This marks a new era for...
PRISM AdTech & Media Company Spotlight: Creative Realities Illuminates the Future of Experiential Design
In the fast-paced landscape of experiential design and technology, Creative Realities Inc. seamlessly integrates the physical and digital realms in creating immersive experiences that captivate audiences across various industries. NEW YORK, NY, December 16, 2023 - Creative Realities specializes in interactive displays, immersive retail solutions, and cutting-edge content creation to reshape how individuals connect with brands and spaces. With a commitment to innovation and a client-centric...
Rogue One Provides Corporate Update
WASHINGTON, DC, December 15, 2023 -As many are aware, Rogue One, Inc. ("Company") has not submitted any financial statements subsequent to the Quarterly Report dated September 30, 2021. It is imperative to note that the recent action undertaken by the Securities and Exchange Commission on December 5, 2023, was not involuntary, but a result of a negotiated ‘Stipulation Letter' with the SEC which leads to revoking our 12G securities registration status. Consequently, Rogue One, Inc is no longer...
PRISM MediaWire – Weekly Press Resume – Dec. 11 to Dec. 15, 2023
New York, December 15, 2023 PRISM MediaWire - Weekly Press Resume Dec. 11 to Dec. 15, 2023 UAT Group Receives Financing for Iron Removal System https://prismmediawire.com/uat-group-receives-financing-for-iron-removal-system/ SKYX and GE Sign a Five-Year Renewal of a Global Licensing Master Service Agreement as SKYX Continues to Enhance its Market Penetration and Collaborations with U.S. and World Leading Strategic Companies...
“Exceptional Result”: NeuroSense Therapeutics Reports New Positive Data from ALS Trial
NEW YORK, NY, December 15, 2023 - NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) has reported additional positive efficacy data from its Phase 2b trial evaluating PrimeC, the company’s lead drug candidate for amyotrophic lateral sclerosis (ALS). The company’s share price rose nearly 30% in trading on Thursday. https://prismmarketview.com/companies/neurosense-therapeutics-ltd/ Alon Ben-Noon, NeuroSense’s CEO, commented, “As we analyze the PARADIGM trial results, we continue to gain a better...
CORRECTION FROM SOURCE: SinglePoint, Inc. – The Inaugural US Company to List on Cboe BZX Exchange
Correcting number of shares in previous Press Release SinglePoint, Inc. common stock to begin trading on Cboe BZX Exchange on December 15th, 2023, under the symbol “SING” Simultaneous capital raise of $4 Million Enable the Company to fully execute its national acquisition strategy and expand solar, battery, EV charging businesses Phoenix, AZ, December 15, 2023 - SinglePoint, Inc. (Cboe BZX: SING) ("SinglePoint" or "the Company"), a renewable solar energy and sustainable solutions provider,...
SinglePoint, Inc.–The Inaugural US Company to List on Cboe BZX Exchange
SinglePoint, Inc. common stock to begin trading on Cboe BZX Exchange on December 15th, 2023, under the symbol “SING” Simultaneous capital raise of $4 Million Enable the Company to fully execute its national acquisition strategy and expand solar, battery, EV charging businesses Phoenix, AZ, December 15, 2023 - SinglePoint, Inc. (Cboe BZX: SING) ("SinglePoint" or "the Company"), a renewable solar energy and sustainable solutions provider, announced today that its shares of common stock to begin...